Folgen
Mohit Kumar Jolly
Mohit Kumar Jolly
Associate Professor, Indian Institute of Science, Bangalore
Bestätigte E-Mail-Adresse bei iisc.ac.in - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Implications of the hybrid epithelial/mesenchymal phenotype in metastasis
MK Jolly, M Boareto, B Huang, D Jia, M Lu, JN Onuchic, H Levine, ...
Frontiers in Oncology 5, 155, 2015
7682015
MicroRNA-based regulation of epithelial–hybrid–mesenchymal fate determination
M Lu, MK Jolly, H Levine, JN Onuchic, E Ben-Jacob
Proceedings of the National Academy of Sciences 110 (45), 18144-18149, 2013
5342013
Tumor budding: the name is EMT. Partial EMT.
AD Grigore, MK Jolly, D Jia, MC Farach-Carson, H Levine
Journal of clinical medicine 5 (5), 51, 2016
5332016
EMT and MET: necessary or permissive for metastasis?
MK Jolly, KE Ware, S Gilja, JA Somarelli, H Levine
Molecular Oncology, 2017
4232017
Stability of the hybrid epithelial/mesenchymal phenotype
MK Jolly, SC Tripathi, D Jia, SM Mooney, M Celiktas, SM Hanash, ...
Oncotarget 7 (19), 27067-27084, 2016
4112016
Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas
MK Jolly, JA Somarelli, M Sheth, A Biddle, SC Tripathi, AJ Armstrong, ...
Pharmacology & therapeutics 194, 161-184, 2019
2872019
Toward understanding cancer stem cell heterogeneity in the tumor microenvironment
F Bocci, L Gearhart-Serna, M Boareto, M Ribeiro, E Ben-Jacob, GR Devi, ...
Proceedings of the National Academy of Sciences 116 (1), 148-157, 2019
2812019
Epithelial–mesenchymal transition, a spectrum of states: role in lung development, homeostasis, and disease
MK Jolly, C Ward, MS Eapen, S Myers, O Hallgren, H Levine, SS Sohal
Developmental dynamics 247 (3), 346-358, 2018
2352018
Survival outcomes in cancer patients predicted by a partial EMT gene expression scoring metric
JT George, MK Jolly, S Xu, JA Somarelli, H Levine
Cancer research 77 (22), 6415-6428, 2017
2182017
Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome
SC Tripathi, HL Peters, A Taguchi, H Katayama, H Wang, A Momin, ...
Proceedings of the National Academy of Sciences 113 (11), E1555-E1564, 2016
1942016
Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing
AP Deshmukh, SV Vasaikar, K Tomczak, S Tripathi, P Den Hollander, ...
Proceedings of the National Academy of Sciences 118 (19), e2102050118, 2021
1902021
Acute vs. chronic vs. cyclic hypoxia: their differential dynamics, molecular mechanisms, and effects on tumor progression
K Saxena, MK Jolly
Biomolecules 9 (8), 339, 2019
1892019
Towards elucidating the connection between epithelial–mesenchymal transitions and stemness
MK Jolly, B Huang, M Lu, SA Mani, H Levine, E Ben-Jacob
Journal of The Royal Society Interface 11 (101), 20140962, 2014
1872014
Coupling the modules of EMT and stemness: A tunable 'stemness window' model.
MK Jolly, D Jia, M Boareto, SA Mani, KJ Pienta, E Ben-Jacob, H Levine
Oncotarget 6 (28), 25161-25174, 2015
1742015
Hypoxia, partial EMT and collective migration: emerging culprits in metastasis
K Saxena, MK Jolly, K Balamurugan
Translational Oncology 13 (11), 100845, 2020
1712020
Jagged–Delta asymmetry in Notch signaling can give rise to a Sender/Receiver hybrid phenotype
M Boareto, MK Jolly, M Lu, JN Onuchic, C Clementi, E Ben-Jacob
Proceedings of the National Academy of Sciences 112 (5), E402-E409, 2015
1692015
Hybrid epithelial/mesenchymal phenotype (s): The ‘fittest’for metastasis?
MK Jolly, SA Mani, H Levine
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1870 (2), 151-157, 2018
1552018
Cancer stem cell plasticity–a deadly deal
AP Thankamony, K Saxena, R Murali, MK Jolly, R Nair
Frontiers in molecular biosciences 7, 79, 2020
1502020
Phenotypic plasticity, bet-hedging, and androgen independence in prostate cancer: role of non-genetic heterogeneity
MK Jolly, P Kulkarni, K Weninger, J Orban, H Levine
Frontiers in oncology 8, 50, 2018
1402018
Single-cell RNA-seq identifies cell subsets in human placenta that highly expresses factors driving pathogenesis of SARS-CoV-2
N Ashary, A Bhide, P Chakraborty, S Colaco, A Mishra, K Chhabria, ...
Frontiers in cell and developmental biology 8, 783, 2020
1392020
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20